184 related articles for article (PubMed ID: 9108450)
1. Fludarabine triphosphate inhibits nucleotide excision repair of cisplatin-induced DNA adducts in vitro.
Li L; Liu X; Glassman AB; Keating MJ; Stros M; Plunkett W; Yang LY
Cancer Res; 1997 Apr; 57(8):1487-94. PubMed ID: 9108450
[TBL] [Abstract][Full Text] [Related]
2. Use of novel plasmid constructs to demonstrate fludarabine triphosphate inhibition of nucleotide excision repair of a site-specific 1,2-d(GpG) intrastrand cisplatin adduct.
Li MJ; Yang LY
Int J Oncol; 1999 Dec; 15(6):1177-83. PubMed ID: 10568825
[TBL] [Abstract][Full Text] [Related]
3. Fludarabine-mediated repair inhibition of cisplatin-induced DNA lesions in human chronic myelogenous leukemia-blast crisis K562 cells: induction of synergistic cytotoxicity independent of reversal of apoptosis resistance.
Li L; Keating MJ; Plunkett W; Yang LY
Mol Pharmacol; 1997 Nov; 52(5):798-806. PubMed ID: 9351970
[TBL] [Abstract][Full Text] [Related]
4. Arabinosyl-2-fluoroadenine augments cisplatin cytotoxicity and inhibits cisplatin-DNA cross-link repair.
Yang LY; Li L; Keating MJ; Plunkett W
Mol Pharmacol; 1995 May; 47(5):1072-9. PubMed ID: 7746274
[TBL] [Abstract][Full Text] [Related]
5. Fludarabine-mediated inhibition of nucleotide excision repair induces apoptosis in quiescent human lymphocytes.
Sandoval A; Consoli U; Plunkett W
Clin Cancer Res; 1996 Oct; 2(10):1731-41. PubMed ID: 9816124
[TBL] [Abstract][Full Text] [Related]
6. Polymerization by DNA polymerase eta is blocked by cis-diamminedichloroplatinum(II) 1,3-d(GpTpG) cross-link: implications for cytotoxic effects in nucleotide excision repair-negative tumor cells.
Chijiwa S; Masutani C; Hanaoka F; Iwai S; Kuraoka I
Carcinogenesis; 2010 Mar; 31(3):388-93. PubMed ID: 20015866
[TBL] [Abstract][Full Text] [Related]
7. Measurement of damage-specific DNA incision by nucleotide excision repair in vitro.
Calsou P; Salles B
Biochem Biophys Res Commun; 1994 Jul; 202(2):788-95. PubMed ID: 8048950
[TBL] [Abstract][Full Text] [Related]
8. Fludarabine-mediated suppression of the excision repair enzyme ERCC1 contributes to the cytotoxic synergy with the DNA minor groove crosslinking agent SJG-136 (NSC 694501) in chronic lymphocytic leukaemia cells.
Pepper C; Lowe H; Fegan C; Thurieau C; Thurston DE; Hartley JA; Delavault P
Br J Cancer; 2007 Jul; 97(2):253-9. PubMed ID: 17579621
[TBL] [Abstract][Full Text] [Related]
9. p53-dependent global nucleotide excision repair of cisplatin-induced intrastrand cross links in human cells.
Bhana S; Hewer A; Phillips DH; Lloyd DR
Mutagenesis; 2008 Mar; 23(2):131-6. PubMed ID: 18267949
[TBL] [Abstract][Full Text] [Related]
10. Resistance of human nucleotide excision repair synthesis in vitro to p21Cdn1.
Shivji MK; Ferrari E; Ball K; Hübscher U; Wood RD
Oncogene; 1998 Dec; 17(22):2827-38. PubMed ID: 9879989
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of repair of carboplatin-induced DNA damage by 9-beta-D-arabinofuranosyl-2-fluoroadenine in quiescent human lymphocytes.
Takagi K; Kawai Y; Yamauchi T; Ueda T
Biochem Pharmacol; 2004 Nov; 68(9):1757-66. PubMed ID: 15450941
[TBL] [Abstract][Full Text] [Related]
12. Effects of a piperidine ligand on DNA modification by antitumor cisplatin analogues.
Kasparkova J; Novakova O; Najajreh Y; Gibson D; Perez JM; Brabec V
Chem Res Toxicol; 2003 Nov; 16(11):1424-32. PubMed ID: 14615968
[TBL] [Abstract][Full Text] [Related]
13. DNA repair initiated in chronic lymphocytic leukemia lymphocytes by 4-hydroperoxycyclophosphamide is inhibited by fludarabine and clofarabine.
Yamauchi T; Nowak BJ; Keating MJ; Plunkett W
Clin Cancer Res; 2001 Nov; 7(11):3580-9. PubMed ID: 11705880
[TBL] [Abstract][Full Text] [Related]
14. Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs.
Pietras RJ; Pegram MD; Finn RS; Maneval DA; Slamon DJ
Oncogene; 1998 Oct; 17(17):2235-49. PubMed ID: 9811454
[TBL] [Abstract][Full Text] [Related]
15. Nucleotide excision repair from site-specifically platinum-modified nucleosomes.
Wang D; Hara R; Singh G; Sancar A; Lippard SJ
Biochemistry; 2003 Jun; 42(22):6747-53. PubMed ID: 12779329
[TBL] [Abstract][Full Text] [Related]
16. Molecular evidence of the involvement of the nucleotide excision repair (NER) system in the repair of the mono(ADP-ribosyl)ated DNA adduct produced by pierisin-1, an apoptosis-inducing protein from the cabbage butterfly.
Kawanishi M; Matsukawa K; Kuraoka I; Takamura-Enya T; Totsuka Y; Matsumoto Y; Watanabe M; Zou Y; Tanaka K; Sugimura T; Wakabayashi K; Yagi T
Chem Res Toxicol; 2007 Apr; 20(4):694-700. PubMed ID: 17381135
[TBL] [Abstract][Full Text] [Related]
17. Role of fludarabine in hematological malignancies.
Montillo M; Ricci F; Tedeschi A
Expert Rev Anticancer Ther; 2006 Sep; 6(9):1141-61. PubMed ID: 17020450
[TBL] [Abstract][Full Text] [Related]
18. Repair synthesis assay for nucleotide excision repair activity using fractionated cell extracts and UV-damaged plasmid DNA.
Biggerstaff M; Wood RD
Methods Mol Biol; 2006; 314():417-34. PubMed ID: 16673897
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of fludarabine cytotoxicity on non-Hodgkin's lymphoma by pentoxifylline and rituximab.
Alas S; Bonavida B; Emmanouilides C
Anticancer Res; 2000; 20(5A):2961-6. PubMed ID: 11062708
[TBL] [Abstract][Full Text] [Related]
20. Chromium(VI) enhances (+/-)-anti-7beta,8alpha-dihydroxy-9alpha,10alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene-induced cytotoxicity and mutagenicity in mammalian cells through its inhibitory effect on nucleotide excision repair.
Hu W; Feng Z; Tang MS
Biochemistry; 2004 Nov; 43(44):14282-9. PubMed ID: 15518579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]